Home> Blog> China Top 10 Rabies Immune Globulin Vaccine Potential Enterprises

China Top 10 Rabies Immune Globulin Vaccine Potential Enterprises

May 05, 2024
The rabies immune globulin vaccine market is expected to witness significant growth due to increasing awareness about Rabies Prevention, rising cases of rabies infections, and government initiatives for mass vaccination programs. Advancements in vaccine technology and growing research and development activities are also contributing to the market growth.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.

website : www.kangtai.com

Main Product : Kangtai specializes in producing vaccines, blood products, and diagnostic reagents.

Company Profile

With a focus on innovation and research, Kangtai continues to expand its product offerings and market reach.

Changchun Institute of Biological Products Co., Ltd.

Establishment time : 1956

website : http://www.cibp.cnbio.com/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products Co., Ltd. is a leading manufacturer of vaccines and biological products in China. Established in 1956, the company has a strong presence in both domestic and international markets. With a large company size and a focus on research and development, CIBP is known for its high-quality products and competitive position in the industry. Visit their website for more information on their products and services.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Shanghai Institute of Biological Products Co., Ltd.

Establishment time : 1969

website : http://www.shpi.com.cn/

Main Product : Vaccines, biological products

Company Profile

Shanghai Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. Established in 1969, the company has grown to become a key player in the healthcare industry, serving both domestic and international markets. With a large production capacity and a strong focus on innovation, the company is dedicated to providing high-quality and effective healthcare solutions to improve public health.

Liaoning Chengda Biotechnology Co., Ltd.

Establishment time : 2002

website : http://www.chengdabio.com/

Main Product : Probiotics, feed additives, veterinary drugs

Company Profile

Liaoning Chengda Biotechnology Co., Ltd. is a leading manufacturer and supplier of probiotics, feed additives, and veterinary drugs in China. With a focus on research and development, the company has a strong commitment to providing innovative and high-quality products to improve animal health and nutrition. Established in 2002, Chengda Biotechnology has grown into a reputable company with a diverse product portfolio and a presence in both domestic and international markets.

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1967.

website : http://www.whbp.com.cn/.

Main Product : Their main products are vaccines.

Company Profile

Wuhan Institute of Biological Products Co., Ltd. is known for its high-quality products and innovative research in the field of biological products.

Beijing Tiantan Biological Products Co., Ltd.

Establishment time : 1992

website : www.btbp.com.cn

Main Product : vaccines, blood products, and diagnostic reagents

Company Profile

Beijing Tiantan Biological Products Co., Ltd. is a pioneering biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Established in 1992, the company has grown to become a major player in the global biopharmaceutical industry, with a strong presence in markets across China, Asia, Africa, and Latin America. With a large workforce of over 1,000 employees, Beijing Tiantan Biological Products Co., Ltd. is committed to providing safe and effective healthcare solutions to people around the world.

Guangdong Shuanglin Bio-Pharmacy Co., Ltd.

Establishment time : 1995

website : www.shuanglinpharma.com

Main Product : Active pharmaceutical ingredients (APIs), pharmaceutical intermediates

Company Profile

Guangdong Shuanglin Bio-Pharmacy Co., Ltd. is a leading pharmaceutical company specializing in the production of APIs and pharmaceutical intermediates. Established in 1995, the company has a strong presence in both domestic and international markets, with a focus on quality and innovation to meet the needs of customers worldwide. With a medium-sized company size, Guangdong Shuanglin Bio-Pharmacy Co., Ltd. continues to strive for excellence in the pharmaceutical industry.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 1998

website : www.tianyuanpharm.com

Main Product : Heparin Sodium, Enoxaparin Sodium, Hyaluronic Acid, Chondroitin Sulfate, etc.

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a reputable pharmaceutical company specializing in the production of various pharmaceutical raw materials, including heparin sodium, enoxaparin sodium, hyaluronic acid, and chondroitin sulfate. With a focus on innovation, quality, and customer satisfaction, the company has become a trusted partner for pharmaceutical companies worldwide.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : Chengdu Institute of Biological Products Co., Ltd. was founded in 1967 and has since become a prominent player in the field of vaccine and biological product manufacturing.

website :

Main Product : With a strong presence in China and a growing market share in international markets, Chengdu Institute of Biological Products Co., Ltd. is considered a key player in the industry.

Company Profile

Overall, Chengdu Institute of Biological Products Co., Ltd. is a leading player in the industry, known for its quality products and commitment to innovation.
Contact Us

Author:

Mr. Simba Li

Phone/WhatsApp:

+86 18946525326

Popular Products
You may also like
Related Information
Top 10 Rabies Immune Globulin Vaccine Manufacturers

Protect yourself from rabies with the Rabies Immune Globulin Vaccine! This life-saving vaccine can prevent the spread of rabies if you've been exposed to the virus. Stay safe and get vaccinated today...

List of Top 10 Rabies Immune Globulin Vaccine Brands Popular in European and American Countries

Rabies Immune Globulin Vaccine is a crucial component in preventing rabies infection. It is administered to individuals who have been exposed to the rabies virus to provide immediate protection. The...

Top 10 Most Popular Chinese Rabies Immune Globulin Vaccine Brands

Rabies Immune Globulin (RIG) is a sterile solution made from human blood plasma that contains high levels of antibodies against the rabies virus. It is used in combination with the rabies vaccine to...

Asia's Top 10 Rabies Immune Globulin Vaccine Brand List

The rabies immune globulin vaccine market is expected to witness significant growth due to increasing awareness about rabies prevention, rising incidence of rabies cases, and advancements in vaccine...

Related Categories

Email to this supplier

Subject:
Email:
Message:

Your message must be betwwen 20-8000 characters

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send